TrialBMC nephrology2013

Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial.

Valentina Forni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.